Ensign Group Inc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Ensign Group Inc's ROA in the third quarter of 2026?
Ensign Group Inc achieved a return on average assets (ROA) of 7 % in its third quarter of 2026, this is above ENSG's average return on assets of 5.99%.
Ensign Group Incs assets during the 12 months ending in the third quarter of 2026 are valued at $5 billion

ROA has improved compared to 6.88% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 125 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 918, from total ROA ranking in the second quarter of 2026 at 1071.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	14.77 %	16.61 %	17.9 %	20.59 %	15.72 %
Y / Y Net Income Change	24.25 %	18.19 %	24.15 %	19.79 %	6.8 %
Net Income (TTM) in million	399	379	364	344	328
Return On Assets (TTM)	7 %	6.88 %	6.85 %	6.76 %	6.76 %
ENSG's Total Ranking	# 918	# 1071	# 927	# 922	# 941
Total Assets (TTM) in million	5,998	5,749	5,612	5,463	5,226
Seq. Total Assets Change	4.33 %	2.45 %	2.72 %	4.53 %	6.01 %
Seq. Net Income Change	4.44 %	0.08 %	4.42 %	13.85 %	-0.66 %

ENSG's 5 Years Annual ROA >> Back to ENSG Management Effectiveness >> Compare ENSG ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 126
Overall	# 892

Return On Assets Statistics
High	Average	Low
9.05 %	5.99 %	-0.27 %
(Jun 30 2015)

Financial Statements
Ensign Group Inc's Assets	$ 5,998 million	ENSG's Balance sheet
Ensign Group Inc's Income	$ 104 million	Quarterly ENSG's Income Statement
ENSG's Income by Division		See ENSG's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	20.59 %	10.82 %	20.72 %	20.26 %	11.95 %
Total Assets in million	5,463	4,530	4,088	3,386	2,816
Y / Y Net Income Change	15.35 %	42.22 %	-6.59 %	13.62 %	15.38 %
Net Income in million	344	298	210	225	198
Annual Return On Assets	6.3 %	6.59 %	5.13 %	6.63 %	7.02 %

ENSG's 5 Years Annual ROA >> Back to ENSG Management Effectiveness >> Compare ENSG ROA to its Competitors

Comment on ENSG's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 6.3 %, despite annual net income growth of 15.35 % to $344.26 million, from $298.46 million a year ago, as ENSG's assets increase to $5,462.97 million, by 15.35 %.

More Return On Assets Ratios
ENSG's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ENSG's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ENSG's Competitors
Subscribers only: Roa for Ensign Group Inc's Suppliers
Subscribers only: Return On Assets for ENSG's Customers

You may also want to know
ENSG's Roi	ENSG's Inventory Turnover Ratio	ENSG's Growth Rates	ENSG's Dividend Comparisons
	ENSG's Profitability Ratios	ENSG's Asset Turnover Ratio	ENSG's Dividend Growth
ENSG's Roe	ENSG's Valuation Ratios	ENSG's Financial Strength Ratios	ENSG's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Alpha Pro Tech Ltd	12.46 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Beone Medicines Ltd	10.23 %
Amgen Inc	10.02 %

Date modified: 2026-10-28T09:24:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.